CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −1,675 | $4.61 | $8K | 109,288 |
| 2026-02-27 | Phanstiel S. Louise Director | Purchase | +48,000 | $4.66 | $224K | 281,951 |
| 2026-02-26 | Phanstiel S. Louise Director | Purchase | +50,407 | $4.80 | $242K | 233,951 |
| 2026-02-25 | Phanstiel S. Louise Director | Purchase | +6,100 | $4.74 | $29K | 183,544 |
| 2026-02-02 | Wheeler Benjamin Richard Chief Financial Officer | Grant or award | +4,994 | 97,624 | ||
| 2026-02-02 | Muzzey Dale Chief Scientific Officer | Grant or award | +23,697 | 193,878 | ||
| 2026-02-02 | Haas Kevin Richard Chief Technology Officer | Grant or award | +23,697 | 202,332 | ||
| 2026-02-02 | Verratti Mark Chief Operating Officer | Grant or award | +32,810 | 414,636 | ||
| 2026-01-01 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −418 | $6.15 | $3K | 170,181 |
| 2025-12-25 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −21 | $6.55 | $138 | 92,630 |
| 2025-12-11 | Raha Samraat S. President and CEO | Shares withheld for taxes | −29,634 | $7.30 | $216K | 453,104 |
| 2025-09-21 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −2,559 | $7.77 | $20K | 92,651 |
| 2025-09-21 | Munk Natalie Chief Accounting Officer | Shares withheld for taxes | −962 | $7.77 | $7K | 45,167 |
| 2025-09-21 | Ancona Margaret EVP, Strategy & Transformation | Shares withheld for taxes | −958 | $7.77 | $7K | 127,726 |
| 2025-09-21 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −1,085 | $7.77 | $8K | 381,826 |
| 2025-09-03 | Fox Jennifer Lynne Chief Legal Officer | Shares withheld for taxes | −4,435 | $6.80 | $30K | 120,481 |
| 2025-08-16 | Wheeler Benjamin Richard Chief Financial Officer | Grant or award | +60,000 | 95,210 | ||
| 2025-06-05 | Dreismann Heinrich Director | Grant or award | +49,796 | 171,444 | ||
| 2025-06-05 | Bisaro Paul Director | Grant or award | +49,796 | 89,941 | ||
| 2025-06-05 | Davis Mark Steven Director | Grant or award | +24,148 | 46,964 |
Page 4 of 15 · 286 trades